Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-15 Kovacs Shane William Charles Ch. Operating & Financial Off. Grant or award +358,680 358,680
2020-06-15 Harmon Cyrus Chief Technology Officer Grant or award +143,472 1,040,172
2020-06-10 Horn Kinney Chief Business Officer Grant or award · Stock Option (Right to Buy) +252,060 252,060
2020-06-01 Graham G. Walmsley Director Purchase · Series B Convertible Preferred Stock +339,578 $4.71 $1.6M 1,400,761
2020-06-01 Graham G. Walmsley Director Purchase · Series B Convertible Preferred Stock +339,578 $4.71 $1.6M 339,578

Page 24 of 24 · 465 trades